Related Experiment Video
Updated: May 8, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Core competencies for pharmaceutical physicians and drug development scientists
Honorio Silva1, Peter Stonier, Fritz Buhler
1IFAPP Working Group on Competencies in Pharmaceutical Medicine Netherlands.
Frontiers in Pharmacology
|August 30, 2013
Summary
A working group defined 60 core competencies for pharmaceutical physicians and drug development scientists. These competencies align with PharmaTrain
Area of Science:
- Pharmaceutical Medicine
- Drug Development Science
- Medical Education
Background:
- Professional organizations like IFAPP are crucial for defining core competencies in pharmaceutical medicine.
- The PharmaTrain project aims to provide postgraduate education for medicines development professionals.
- A collaborative working group integrated expertise from IFAPP, PharmaTrain, academia, and national associations.
Purpose of the Study:
- To define core competencies for pharmaceutical physicians and drug development scientists.
- To summarize these competencies in a Statement of Competence.
- To benchmark and align identified competencies with PharmaTrain Base Course Learning Outcomes.
Main Methods:
- Formation of a multidisciplinary working group.
- Identification and definition of core competency domains.
- Alignment of identified competencies with existing educational frameworks (PharmaTrain LO).
Main Results:
- Successfully identified seven domains encompassing 60 core competencies.
- Achieved alignment between the defined core competencies and PharmaTrain Base Course Learning Outcomes.
- Developed a framework for a Statement of Competence for pharmaceutical physicians and drug development scientists.
Conclusions:
- The defined core competencies and alignment with PharmaTrain provide a global standard for pharmaceutical medicine education.
- Implementation of these competencies can enhance the efficiency and safety of the drug development process.
- The PharmaTrain Base Course offers a potential cognitive framework for achieving worldwide competence standards.
Related Concept Videos
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...